{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:30:18Z","timestamp":1794540618908,"version":"4.9.1"},"reference-count":134,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Quintin Hogg Trust Research Studentship","award":["2043222"],"award-info":[{"award-number":["2043222"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Bone is the most frequent site of distant metastasis in advanced prostate cancer (PCa), contributing substantially to patient morbidity and mortality. Hypoxia, a defining feature of the solid tumour microenvironment, plays a pivotal role in driving bone-tropic progression by promoting epithelial-to-mesenchymal transition (EMT), cancer stemness, extracellular matrix (ECM) remodelling, and activation of key signalling pathways such as Wingless\/Integrated (Wnt) Wnt\/\u03b2-catenin and PI3K\/Akt. Hypoxia also enhances the secretion of extracellular vesicles (EVs), enriched with pro-metastatic cargos, and upregulates bone-homing molecules including CXCR4, integrins, and PIM kinases, fostering pre-metastatic niche formation and skeletal colonisation. In this review, we analysed current evidence on how hypoxia orchestrates PCa dissemination to bone, focusing on the molecular crosstalk between HIF signalling, Wnt activation, EV-mediated communication, and cellular plasticity. We further explore therapeutic strategies targeting hypoxia-related pathways, such as HIF inhibitors, hypoxia-activated prodrugs, and Wnt antagonists, with an emphasis on overcoming therapy resistance in castration-resistant PCa (CRPC). By examining the mechanistic underpinnings of hypoxia-driven bone metastasis, we highlight promising translational avenues for improving patient outcomes in advanced PCa.<\/jats:p>","DOI":"10.3390\/ijms26157452","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:56:16Z","timestamp":1754409376000},"page":"7452","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["From Hypoxia to Bone: Reprogramming the Prostate Cancer Metastatic Cascade"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4757-176X","authenticated-orcid":false,"given":"Melissa","family":"Santos","sequence":"first","affiliation":[{"name":"Cancer Mechanisms and Biomarkers Research Group, School of Life Sciences, University of Westminster, London W1W 6UW, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Koushyar","sequence":"additional","affiliation":[{"name":"UCL Cancer Institute, University College London, Paul O\u2019Gorman Building, 72 Huntley Street, London WC1E 6DD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3801-8583","authenticated-orcid":false,"given":"Dafydd Alwyn","family":"Dart","sequence":"additional","affiliation":[{"name":"UCL Cancer Institute, University College London, Paul O\u2019Gorman Building, 72 Huntley Street, London WC1E 6DD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3190-8831","authenticated-orcid":false,"given":"Pinar","family":"Uysal-Onganer","sequence":"additional","affiliation":[{"name":"Cancer Mechanisms and Biomarkers Research Group, School of Life Sciences, University of Westminster, London W1W 6UW, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3390\/curroncol30020178","article-title":"Underlying Features of Prostate Cancer\u2014Statistics, Risk Factors, and Emerging Methods for Its Diagnosis","volume":"30","author":"Berenguer","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA","volume":"71","author":"Sung","year":"2021","journal-title":"Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Poon, D.M.C., Cheung, W.S.K., Chiu, P.K.F., Chung, D.H.S., Kung, J.B.T., Lam, D.C.M., Leung, A.K.C., Ng, A.C.F., O\u2019Sullivan, J.M., and Teoh, J.Y.C. (2025). Treatment of Metastatic Castration-Resistant Prostate Cancer: Review of Current Evidence and Synthesis of Expert Opinions on Radioligand Therapy. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1530580"},{"key":"ref_4","first-page":"101","article-title":"Targeting Treatment Options for Castration-Resistant Prostate Cancer","volume":"9","author":"Miller","year":"2021","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","article-title":"Human Prostate Cancer Bone Metastases Have an Actionable Immunosuppressive Microenvironment","volume":"39","author":"Kfoury","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ying, M., Mao, J., Sheng, L., Wu, H., Bai, G., Zhong, Z., and Pan, Z. (2023). Biomarkers for Prostate Cancer Bone Metastasis Detection and Prediction. J. Pers. Med., 13.","DOI":"10.3390\/jpm13050705"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wang, Y., Chen, Y., and Wang, J. (2025). Role of Tumor Microenvironment in Prostate Cancer Immunometabolism. Biomolecules, 15.","DOI":"10.3390\/biom15060826"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"15330338211036304","DOI":"10.1177\/15330338211036304","article-title":"Hypoxia and the Tumor Microenvironment","volume":"20","author":"Li","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12935-020-01719-5","article-title":"The Role of Hypoxia in the Tumor Microenvironment and Development of Cancer Stem Cell: A Novel Approach to Developing Treatment","volume":"21","author":"Najafgholian","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e159839","DOI":"10.1172\/JCI159839","article-title":"Hypoxia-Inducible Factors: Cancer Progression and Clinical Translation","volume":"132","author":"Wicks","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tirpe, A.A., Gulei, D., Ciortea, S.M., Crivii, C., and Berindan-Neagoe, I. (2019). Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246140"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2020.06.004","article-title":"Hypoxia in Bone Metastasis and Osteolysis","volume":"489","author":"Todd","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1007\/s11033-023-08251-5","article-title":"The Role of Hypoxia on Prostate Cancer Progression and Metastasis","volume":"50","author":"Mohamed","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"81558","DOI":"10.18632\/oncotarget.18277","article-title":"Epithelial-to-Mesenchymal Transition, Circulating Tumor Cells and Cancer Metastasis: Mechanisms and Clinical Applications","volume":"8","author":"Jie","year":"2017","journal-title":"Oncotarget"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13045-025-01684-4","article-title":"Unraveling the Triad of Hypoxia, Cancer Cell Stemness, and Drug Resistance","volume":"18","author":"Shang","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Makena, M.R., Ranjan, A., Thirumala, V., and Reddy, A.P. (2020). Cancer Stem Cells: Road to Therapeutic Resistance and Strategies to Overcome Resistance. Biochim. Biophys. Acta BBA-Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2018.11.015"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Tse, S.W., Tan, C.F., Park, J.E., Gnanasekaran, J., Gupta, N., Low, J.K., Yeoh, K.W., Chng, W.J., Tay, C.Y., and McCarthy, N.E. (2020). Microenvironmental Hypoxia Induces Dynamic Changes in Lung Cancer Synthesis and Secretion of Extracellular Vesicles. Cancers, 12.","DOI":"10.21203\/rs.3.rs-42528\/v1"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Clemente-Gonz\u00e1lez, C., and Carnero, A. (2022). Role of the Hypoxic-Secretome in Seed and Soil Metastatic Preparation. Cancers, 14.","DOI":"10.3390\/cancers14235930"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/pgr2.1","article-title":"Extracellular Vesicles Released during Hypoxia Transport Heparanase and Enhance Macrophage Migration, Endothelial Tube Formation and Cancer Cell Stemness","volume":"1","author":"Tripathi","year":"2023","journal-title":"Proteoglycan Res."},{"key":"ref_20","unstructured":"Reboud, L. (2023). Modifying the Bone Metastatic Niche by Targeting the Hypoxic Response: A Novel Therapeutic Approach to Reduce Breast Cancer Metastasis. [Ph.D. Thesis, The University of Manchester]."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Gilkes, D.M. (2016). Implications of Hypoxia in Breast Cancer Metastasis to Bone. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17101669"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/CMAR.S495169","article-title":"Prostate Cancer Bone Metastasis: Molecular Mechanisms of Tumor and Bone Microenvironment","volume":"17","author":"Jiang","year":"2025","journal-title":"Cancer Manag. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Magar, A.G., Morya, V.K., Kwak, M.K., Oh, J.U., and Noh, K.C. (2024). A Molecular Perspective on HIF-1\u03b1 and Angiogenic Stimulator Networks and Their Role in Solid Tumors: An Update. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063313"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/bjp.2008.70","article-title":"Rapid Degradation of Hypoxia-Inducible Factor-1\u03b1 by KRH102053, a New Activator of Prolyl Hydroxylase 2","volume":"154","author":"Choi","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ullah, K., Ai, L., Humayun, Z., and Wu, R. (2023). Targeting Endothelial HIF2\u03b1\/ARNT Expression for Ischemic Heart Disease Therapy. Biology, 12.","DOI":"10.3390\/biology12070995"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zimna, A., and Kurpisz, M. (2015). Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies. BioMed Res. Int., 2015.","DOI":"10.1155\/2015\/549412"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Gaete, D., Rodriguez, D., Watts, D., Sormendi, S., Chavakis, T., and Wielockx, B. (2021). HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer\u2014Potential Targets for Anti-Tumor Therapy?. Cancers, 13.","DOI":"10.3390\/cancers13050988"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bakleh, M.Z., and Al Haj Zen, A. (2025). The Distinct Role of HIF-1\u03b1 and HIF-2\u03b1 in Hypoxia and Angiogenesis. Cells, 14.","DOI":"10.3390\/cells14090673"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cmet.2020.08.002","article-title":"The Role of HIF in Immunity and Inflammation","volume":"32","author":"McGettrick","year":"2020","journal-title":"Cell Metab."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Song, L., Zhu, H., Zhang, J., Luo, Y., Wei, C., Li, Y., Han, K., Su, S., and Wang, D. (2024). HIF-1\u03b1 Affects Invasion and Metastasis of Prostate Cancer by Regulating Invadopodia Formation. Res. Sq.","DOI":"10.21203\/rs.3.rs-4867481\/v1"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Walbrecq, G., Margue, C., Behrmann, I., and Kreis, S. (2020). Distinct Cargos of Small Extracellular Vesicles Derived from Hypoxic Cells and Their Effect on Cancer Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21145071"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Chellini, F., Tani, A., Parigi, M., Palmieri, F., Garella, R., Zecchi-Orlandini, S., Squecco, R., and Sassoli, C. (2023). HIF-1\u03b1\/MMP-9 Axis Is Required in the Early Phases of Skeletal Myoblast Differentiation under Normoxia Condition In Vitro. Cells, 12.","DOI":"10.20944\/preprints202311.0533.v1"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4048\/jbc.2011.14.2.88","article-title":"Overexpression of MMP-9 and HIF-1\u03b1 in Breast Cancer Cells under Hypoxic Conditions","volume":"14","author":"Choi","year":"2011","journal-title":"J. Breast Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12964-023-01207-z","article-title":"NF-\u03baB Signaling in Neoplastic Transition from Epithelial to Mesenchymal Phenotype. Cell Commun. Signal","volume":"21","author":"Oh","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"825","DOI":"10.33549\/physiolres.934930","article-title":"Hypoxia-Induced Upregulation of Matrix Metalloproteinase 9 Increases Basement Membrane Degradation by Downregulating Collagen Type IV Alpha 1 Chain","volume":"71","author":"Zhu","year":"2022","journal-title":"Physiol. Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Hiraga, T. (2018). Hypoxic Microenvironment and Metastatic Bone Disease. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113523"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13046-022-02520-0","article-title":"Osteoblasts and Osteoclasts: An Important Switch of Tumour Cell Dormancy during Bone Metastasis","volume":"41","author":"Dai","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/iub.2700","article-title":"The Roles of Proteases in Prostate Cancer","volume":"75","author":"Koistinen","year":"2023","journal-title":"IUBMB Life"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-Metastatic Niches: Organ-Specific Homes for Metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/mc.23157","article-title":"Exosomes Secreted by Prostate Cancer Cells under Hypoxia Promote Matrix Metalloproteinases Activity at Pre-Metastatic Niches","volume":"59","author":"Deep","year":"2020","journal-title":"Mol. Carcinog."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Du, G., Huang, X., Su, P., Yang, Y., Chen, S., Huang, T., and Zhang, N. (2025). The Role of SOX Transcription Factors in Prostate Cancer: Focusing on SOX2. Genes Dis., 101692.","DOI":"10.1016\/j.gendis.2025.101692"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2022.01.015","article-title":"Tumor Microenvironment Mechanisms and Bone Metastatic Disease Progression of Prostate Cancer","volume":"530","author":"Kang","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic Microenvironment in Cancer: Molecular Mechanisms and Therapeutic Interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","article-title":"Cancer Cell Plasticity during Tumor Progression, Metastasis and Response to Therapy","volume":"4","author":"Blanpain","year":"2023","journal-title":"Nat. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12943-023-01909-5","article-title":"The Role of Extracellular Vesicles in Circulating Tumor Cell-Mediated Distant Metastasis","volume":"22","author":"Guo","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Mathivanan, S., Fonseka, P., Nedeva, C., and Atukorala, I. (2021). Extracellular Vesicle-Mediated Bone Remodeling and Bone Metastasis: Implications in Prostate Cancer. New Frontiers: Extracellular Vesicles, Springer International Publishing.","DOI":"10.1007\/978-3-030-67171-6"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.59566\/ISRNN.2024.0101016","article-title":"Targeted Delivery of Potent Chemical Drugs and RNAi to Drug-Resistant Breast Cancer Using RNA-Nanotechnology and RNA-Ligand Displaying Extracellular Vesicles","volume":"1","author":"Ho","year":"2024","journal-title":"RNA NanoMed"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Forder, A., Hsing, C.-Y., Trejo Vazquez, J., and Garnis, C. (2021). Emerging Role of Extracellular Vesicles and Cellular Communication in Metastasis. Cells, 10.","DOI":"10.3390\/cells10123429"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Wei, X., Liu, R., Li, W., Yu, Q., Yang, Q.T., and Li, T. (2025). Advances in Research Regarding Epithelial-Mesenchymal Transition and Prostate Cancer. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1583255"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ganguly, S.S., Li, X., and Miranti, C.K. (2014). The Host Microenvironment Influences Prostate Cancer Invasion, Systemic Spread, Bone Colonization, and Osteoblastic Metastasis. Front. Oncol., 4.","DOI":"10.3389\/fonc.2014.00364"},{"key":"ref_51","unstructured":"Duatti, A. (2023). Lactate-Induced COL1A1\/DDR1 Axis Promotes Prostate Cancer Aggressiveness and Enhances Metastatic Colonization. [Ph.D. Thesis, University of Siena]."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Kaya, Z., Christianson, J., Mills, I., Rao, S., and Edwards, C. (2021). Investigating the Contribution of the Unfolded Protein Response to Prostate Cancer Bone Metastasis. J. Nuffield Dep. Surg. Sci., 2.","DOI":"10.37707\/jnds.v2i4.208"},{"key":"ref_53","first-page":"11369","article-title":"Comprehensive Analysis of Integrin Av\u03b23\/A6\u03b21 in Prognosis and Immune Escape of Prostate Cancer","volume":"15","author":"Liu","year":"2023","journal-title":"Aging"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Kan, C., Vargas, G., Le Pape, F., and Cl\u00e9zardin, P. (2016). Cancer Cell Colonisation in the Bone Microenvironment. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17101674"},{"key":"ref_55","first-page":"297","article-title":"Hypoxia-Induced PIM Kinase and Laminin-Activated Integrin A6 Mediate Resistance to PI3K Inhibitors in Bone-Metastatic CRPC","volume":"7","author":"Toth","year":"2019","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Zhou, X., Tian, C., Cao, Y., Zhao, M., and Wang, K. (2023). The Role of Serine Metabolism in Lung Cancer: From Oncogenesis to Tumor Treatment. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.1084609"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12964-024-01898-y","article-title":"PIM1 Kinase and Its Diverse Substrate in Solid Tumors","volume":"22","author":"Choudhury","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-020-0109-y","article-title":"PIM Kinase Inhibition: Co-Targeted Therapeutic Approaches in Prostate Cancer","volume":"5","author":"Luszczak","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1038\/s41388-021-01915-1","article-title":"Direct Phosphorylation and Stabilization of HIF-1\u03b1 by PIM1 Kinase Drives Angiogenesis in Solid Tumors","volume":"40","author":"Casillas","year":"2021","journal-title":"Oncogene"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41420-023-01417-x","article-title":"The Role of Integrin Family in Bone Metabolism and Tumor Bone Metastasis","volume":"9","author":"Mao","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Johnson, C.S., and Cook, L.M. (2023). Osteoid Cell-Derived Chemokines Drive Bone-Metastatic Prostate Cancer. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1100585"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Toth, R.K., Solomon, R., and Warfel, N.A. (2022). Stabilization of PIM Kinases in Hypoxia Is Mediated by the Deubiquitinase USP28. Cells, 11.","DOI":"10.3390\/cells11061006"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Singh, S., Sarma, D.K., Verma, V., Nagpal, R., and Kumar, M. (2023). From Cells to Environment: Exploring the Interplay between Factors Shaping Bone Health and Disease. Medicina, 59.","DOI":"10.3390\/medicina59091546"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semcancer.2023.11.001","article-title":"Hypoxia Signaling and Metastatic Progression. Semin","volume":"97","author":"Schito","year":"2023","journal-title":"Cancer Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"eabo2295","DOI":"10.1126\/sciadv.abo2295","article-title":"Hypoxia-Mediated Stabilization of HIF1A in Prostatic Intraepithelial Neoplasia Promotes Cell Plasticity and Malignant Progression","volume":"8","author":"Terzic","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1615\/CritRevOncog.v20.i5-6.130","article-title":"Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment","volume":"20","author":"Deep","year":"2015","journal-title":"Crit. Rev. Oncog."},{"key":"ref_67","first-page":"1198","article-title":"Inhibition of HIF-1\u03b1 by PX-478 Suppresses Tumor Growth of Esophageal Squamous Cell Cancer in Vitro and in Vivo","volume":"7","author":"Zhu","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.ymthe.2025.02.045","article-title":"Clinical Applications of Oligonucleotides for Cancer Therapy","volume":"33","author":"DeFranciscis","year":"2025","journal-title":"Mol. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1017\/erm.2022.14","article-title":"Exploring Hypoxic Biology to Improve Radiotherapy Outcomes","volume":"24","author":"Li","year":"2022","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1039\/C8CS00304A","article-title":"Hypoxia-Targeted Drug Delivery","volume":"48","author":"Sharma","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.2174\/0929867329666220829095334","article-title":"A Comprehensive Description of Hypoxia-Inducible Factor 2\u03b1 Inhibitors as Anticancer Agents: A Mini-Review","volume":"30","author":"Lu","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Gallez, B. (2022). The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.853568"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1080\/15257770.2024.2311789","article-title":"Cancer Stem Cells: Recent Trends in Cancer Therapy","volume":"43","author":"Taheri","year":"2024","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Papanikolaou, S., Vourda, A., Syggelos, S., and Gyftopoulos, K. (2021). Cell Plasticity and Prostate Cancer: The Role of Epithelial\u2013Mesenchymal Transition in Tumor Progression, Invasion, Metastasis and Cancer Therapy Resistance. Cancers, 13.","DOI":"10.3390\/cancers13112795"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-0716-2815-7_9","article-title":"Targeting Transcription Factors in Cancer: From \u201cUndruggable\u201d to \u201cDruggable","volume":"2594","author":"Tao","year":"2023","journal-title":"\u201d Methods Mol. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Koushyar, S., Meniel, V.S., Phesse, T.J., and Pearson, H.B. (2022). Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer. Biomolecules, 12.","DOI":"10.3390\/biom12020309"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1080\/10942912.2023.2252619","article-title":"Anticancer and Apoptosis Inducing Potential of Quercetin against a Wide Range of Human Malignancies","volume":"26","author":"Shahbaz","year":"2023","journal-title":"Int. J. Food Prop."},{"key":"ref_78","first-page":"189244","article-title":"Hypoxia as a Critical Player in Extracellular Vesicles-Mediated Intercellular Communication between Tumor Cells and Their Surrounding Microenvironment. Biochim. Biophys","volume":"1880","author":"Branco","year":"2025","journal-title":"Acta BBA-Rev. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"100085","DOI":"10.1016\/j.onano.2022.100085","article-title":"EV-out or EV-in: Tackling Cell-to-Cell Communication within the Tumor Microenvironment to Enhance Anti-Tumor Efficacy Using Extracellular Vesicle-Based Therapeutic Strategies","volume":"8","author":"Chiangjong","year":"2022","journal-title":"OpenNano"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/cbf.3695","article-title":"Inhibition of Extracellular Vesicle Biogenesis in Tumor Cells: A Possible Way to Reduce Tumorigenesis","volume":"40","author":"Rezaie","year":"2022","journal-title":"Cell Biochem. Funct."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s43042-024-00582-7","article-title":"Interactions between Cancer and Stroma Mediated by Extracellular Vesicles","volume":"25","author":"Najafzadeh","year":"2024","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Tang, S., Cheng, H., Zang, X., Tian, J., Ling, Z., Wang, L., Xu, W., and Jiang, J. (2025). Small Extracellular Vesicles: Crucial Mediators for Prostate Cancer. J. Nanobiotechnol., 23.","DOI":"10.1186\/s12951-025-03326-w"},{"key":"ref_83","unstructured":"Ku, A. (2020). Harnessing Urinary Extracellular Vesicles microRNA by Acoustic Trapping as Potential Biomarkers for Prostate Cancer. [Ph.D. Thesis, Lund University]."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","article-title":"Regulation of Cargo Selection in Exosome Biogenesis and Its Biomedical Applications in Cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41370-022-00417-w","article-title":"Approaches to Incorporate Extracellular Vesicles into Exposure Science, Toxicology, and Public Health Research","volume":"32","author":"Carberry","year":"2022","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Capuozzo, M., Santorsola, M., Ianniello, M., Ferrara, F., Zovi, A., Petrillo, N., Castiello, R., Fantuz, M.R., Ottaiano, A., and Savarese, G. (2024). Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer. Diseases, 12.","DOI":"10.3390\/diseases12050087"},{"key":"ref_87","first-page":"491","article-title":"Role of Monocarboxylate Transporters and Glucose Transporters in Prostate Cancer","volume":"90","author":"Vovdenko","year":"2023","journal-title":"Urol. J."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Fu, Z., Mowday, A.M., Smaill, J.B., Hermans, I.F., and Patterson, A.V. (2021). Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy. Cells, 10.","DOI":"10.3390\/cells10051006"},{"key":"ref_89","unstructured":"Ashton, J. (2022). Mechanistic Studies of Hypoxia as a Driver of Genomic Instability in Prostate Cancer. [Ph.D. Thesis, The University of Manchester]."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.radonc.2011.05.063","article-title":"miR-210 as a Marker of Chronic Hypoxia, but Not a Therapeutic Target in Prostate Cancer","volume":"101","author":"Quero","year":"2011","journal-title":"Radiother. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Ryniawec, J.M., Coope, M.R., Loertscher, E., Bageerathan, V., de Oliveira Pessoa, D., Warfel, N.A., Cress, A.E., Padi, M., and Rogers, G.C. (2022). GLUT3\/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors. Diagnostics, 12.","DOI":"10.3390\/diagnostics12030676"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.4161\/cc.25843","article-title":"Identifying the Stromal Cell Type That Contributes to Tumor Aggressiveness Associated with Carbonic Anhydrase IX","volume":"12","author":"Bose","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"9778","DOI":"10.3390\/cimb45120611","article-title":"Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer","volume":"45","author":"Lian","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"McKeage, M.J., Jameson, M.B., Ramanathan, R.K., Rajendran, J., Gu, Y., Wilson, W.R., Melink, T.J., and Tchekmedyian, N.S. (2012). PR-104 a Bioreductive Pre-Prodrug Combined with Gemcitabine or Docetaxel in a Phase Ib Study of Patients with Advanced Solid Tumours. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-496"},{"key":"ref_95","unstructured":"Gibson, B. (2011). A Phase Ib, Multi-Center, Open-Label, Dose Escalation Trial of Intravenous PR-104 Given in Combination with Docetaxel or Gemcitabine in Subjects with Solid Tumors."},{"key":"ref_96","unstructured":"Seierstad, T. (2022). MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness."},{"key":"ref_97","unstructured":"University Health Network (2024). Toronto Hypoxia and Stem Cell Content as Aggression Factors in Prostate Cancer."},{"key":"ref_98","unstructured":"The Christie NHS Foundation Trust (2023). Hypoxia-Driven Prostate Cancer Genomics (HYPROGEN)\u2014Illuminating the Genomic Landscape of Hypoxia-Driven Early Metastatic Prostate Cancer."},{"key":"ref_99","unstructured":"ImmunoGenesis (2025). A Phase 1\/2 Immunotherapy Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab in Patients with Advanced Solid Malignancies."},{"key":"ref_100","first-page":"397","article-title":"The Value of Immunotherapy in Pediatric Leukemia and Lymphoma","volume":"14","author":"Salzer","year":"2021","journal-title":"Memo-Mag. Eur. Med. Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Redman, J.M., Gibney, G.T., and Atkins, M.B. (2016). Advances in Immunotherapy for Melanoma. BMC Med., 14.","DOI":"10.1186\/s12916-016-0571-0"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-319-53156-4_5","article-title":"Immunotherapy in NSCLC: A Promising and Revolutionary Weapon","volume":"995","author":"Rolfo","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Rebuzzi, S.E., Rescigno, P., Catalano, F., Mollica, V., Vogl, U.M., Marandino, L., Massari, F., Pereira Mestre, R., Zanardi, E., and Signori, A. (2022). Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives. Cancers, 14.","DOI":"10.3390\/cancers14051245"},{"key":"ref_104","first-page":"210","article-title":"Prostate Cancer Immunotherapy: A Review of Recent Advancements with Novel Treatment Methods and Efficacy","volume":"10","author":"Wang","year":"2022","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/1097-0142(20001101)89:9<2018::AID-CNCR19>3.0.CO;2-Y","article-title":"Increasing Levels of Hypoxia in Prostate Carcinoma Correlate Significantly with Increasing Clinical Stage and Patient Age: An Eppendorf pO2 Study","volume":"89","author":"Movsas","year":"2000","journal-title":"Cancer"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41389-017-0007-5","article-title":"Prostate-Specific PTen Deletion in Mice Activates Inflammatory microRNA Expression Pathways in the Epithelium Early in Hyperplasia Development","volume":"6","author":"Dart","year":"2017","journal-title":"Oncogenesis"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/ijc.29519","article-title":"HIF-1 at the Crossroads of Hypoxia, Inflammation, and Cancer","volume":"138","author":"Balamurugan","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Mezzapelle, R., Leo, M., Caprioglio, F., Colley, L.S., Lamarca, A., Sabatino, L., Colantuoni, V., Crippa, M.P., and Bianchi, M.E. (2022). CXCR4\/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy. Cancers, 14.","DOI":"10.3390\/cancers14092314"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Shi, Y., Riese, D.J., and Shen, J. (2020). The Role of the CXCL12\/CXCR4\/CXCR7 Chemokine Axis in Cancer. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.574667"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 Is a Novel Direct Target of HIF-1\u03b1, and Its Blockade under Hypoxia Enhanced MDSC-Mediated T Cell Activation","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Santagata, S., Ieran\u00f2, C., Trotta, A.M., Capiluongo, A., Auletta, F., Guardascione, G., and Scala, S. (2021). CXCR4 and CXCR7 Signaling Pathways: A Focus on the Cross-Talk Between Cancer Cells and Tumor Microenvironment. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.591386"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Sethumadhavan, S., Silva, M., Philbrook, P., Nguyen, T., Hatfield, S.M., Ohta, A., and Sitkovsky, M.V. (2017). Hypoxia and Hypoxia-Inducible Factor (HIF) Downregulate Antigen-Presenting MHC Class I Molecules Limiting Tumor Cell Recognition by T Cells. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187314"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-020-01820-7","article-title":"Targeting Hypoxia in the Tumor Microenvironment: A Potential Strategy to Improve Cancer Immunotherapy","volume":"40","author":"Wang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"P392","DOI":"10.1186\/2051-1426-3-S2-P392","article-title":"Tumor Hypoxia Drives Immune Suppression and Immunotherapy Resistance","volume":"3","author":"Ai","year":"2015","journal-title":"J. Immunother. Cancer"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"14565","DOI":"10.1073\/pnas.251140998","article-title":"T Cell Infiltration of the Prostate Induced by Androgen Withdrawal in Patients with Prostate Cancer","volume":"98","author":"Mercader","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Datta Chaudhuri, R., Banerjee, D., Banik, A., and Sarkar, S. (2020). Severity and Duration of Hypoxic Stress Differentially Regulates HIF-1\u03b1-Mediated Cardiomyocyte Apoptotic Signaling Milieu during Myocardial Infarction. Arch. Biochem. Biophys., 690.","DOI":"10.1016\/j.abb.2020.108430"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-022-01080-1","article-title":"Hypoxia Signaling in Human Health and Diseases: Implications and Prospects for Therapeutics","volume":"7","author":"Luo","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41588-018-0318-2","article-title":"Molecular Landmarks of Tumor Hypoxia across Cancer Types","volume":"51","author":"Bhandari","year":"2019","journal-title":"Nat. Genet."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s11547-023-01644-3","article-title":"Prediction of Prostate Tumour Hypoxia Using Pre-Treatment MRI-Derived Radiomics: Preliminary Findings","volume":"128","author":"Zhong","year":"2023","journal-title":"Radiol. Med."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Ci, X., Chen, S., Zhu, R., Zarif, M., Jain, R., Guo, W., Ramotar, M., Gong, L., Xu, W., and Singh, O. (2024). Oral Pimonidazole Unveils Clinicopathologic and Epigenetic Features of Hypoxic Tumour Aggressiveness in Localized Prostate Cancer. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12505-1"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Steingold, J.M., and Hatfield, S.M. (2020). Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.570041"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Wei, J., Hu, M., and Du, H. (2022). Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia Microenvironment. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.845923"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Bigos, K.J., Quiles, C.G., Lunj, S., Smith, D.J., Krause, M., Troost, E.G., West, C.M., Hoskin, P., and Choudhury, A. (2024). Tumour Response to Hypoxia: Understanding the Hypoxic Tumour Microenvironment to Improve Treatment Outcome in Solid Tumours. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1331355"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Li, S., and Wang, W. (2021). Extracellular Vesicles in Tumors: A Potential Mediator of Bone Metastasis. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.639514"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.15419\/bmrat.v9i10.774","article-title":"Roles of Hypoxia in Tumor Progression and Novel Strategies for Cancer Treatment","volume":"9","author":"Khan","year":"2022","journal-title":"Biomed. Res. Ther."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Eckert, F., Schilbach, K., Klumpp, L., Bardoscia, L., Sezgin, E.C., Schwab, M., Zips, D., and Huber, S.M. (2018). Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.03018"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and Hot Tumors: From Molecular Mechanisms to Targeted Therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s43046-023-00186-z","article-title":"Mechanisms of HIF-Driven Immunosuppression in Tumour Microenvironment","volume":"35","author":"Bandopadhyay","year":"2023","journal-title":"J. Egypt. Natl. Cancer Inst."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13045-022-01320-5","article-title":"Enhancing the Therapeutic Efficacy of Nanoparticles for Cancer Treatment Using Versatile Targeted Strategies","volume":"15","author":"Tian","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3892\/ol.2023.13749","article-title":"Prostate Cancer Bone Metastases Biology and Clinical Management (Review)","volume":"25","author":"Wang","year":"2023","journal-title":"Oncol. Lett."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s10555-024-10210-w","article-title":"The Biological Function of Extracellular Vesicles in Prostate Cancer and Their Clinical Application as Diagnostic and Prognostic Biomarkers","volume":"43","author":"Limonta","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Govindarajan, B., Sbrissa, D., Pressprich, M., Kim, S., Rishi, A.K., Vaishampayan, U., Cher, M.L., and Chinni, S.R. (2023). Adaptor Proteins Mediate CXCR4 and PI4KA Crosstalk in Prostate Cancer Cells and the Significance of PI4KA in Bone Tumor Growth. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-47633-4"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Brown, T.J., Rutland, C.S., Choi, K.K., Tse, F., Peffers, M.J., Mongan, N.P., Arkill, K.P., Ritchie, A., Clarke, P.A., and Ratan, H. (2024). Modulation of the Pre-Metastatic Bone Niche: Molecular Changes Mediated by Bone-Homing Prostate Cancer Extracellular Vesicles. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1354606"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"153978","DOI":"10.1016\/j.cej.2024.153978","article-title":"Tailoring Polymeric Nanocarriers for Hypoxia-Specific Drug Release: Insights into Design and Applications in Clinics","volume":"496","author":"Sharma","year":"2024","journal-title":"Chem. Eng. J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7452\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:21:12Z","timestamp":1760034072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":134,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157452"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157452","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}